Antithrombotic effect of ligustrazine hydrochloride injection on the model of induced arteriovenous shunt thrombosis

Journal of Research in Medical Sciences

Volumn 18, Issue 8, 2013, Pages 704-706

  Wang, Peng ^a   Luo, Chun Hua ^a   Wang, Qun Xing ^a   Li, Qian Yuan ^a   Li, Peng ^a   Yuan, Xiao Hui ^b  

^a CHINA THREE GORGES UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Anti thrombotic; Heparin; Ligustrazine hydrochloride injection

Indexed keywords

ANTITHROMBIN; ATROPINE; HEPARIN; TETRAMETHYLPYRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS SHUNT THROMBOSIS; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; MALE; NONHUMAN; RAT; SHUNT THROMBOSIS; THROMBUS;

EID: 84884741948     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sheu JR, Kan YC, Hung WC, Lin CH, Yen MH. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase. Life Sci 2000;67:937-947.
2. Cheng XC, Liu XY, Xu WF, Guo XL, Zhang N, Song YN. Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents. Bioorg Med Chem 2009;17:3018-3024.
3. Sheu JR, Kan YC, Hung WC, Ko WC, Yen MH. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Thromb Res 1997;88:259-270.
4. Jiang F, Qian J, Chen S, Zhang W, Liu C. Ligustrazine improves atherosclerosis in rat via atenuation of oxidative stress. Pharm Biol 2011;49:856-863.
5. Li WM, Liu HT, Li XY, Wu JY, Xu G, Teng YZ, et al. The effect of tetramethylpyrazine on hydrogen peroxide-induced oxidative damage in human umbilical vein endothelial cells. Basic Clin Pharmacol Toxicol 2010;106:45-52.
6. Sheu JR, Hsiao G, Lee YM, Yen MH. Antithrombotic effects of tetramethylpyrazine in vivo experiments. Int J Hematol 2001;73:393-398.
7. Guo XL, Huang XZ, Shi D. Cardiac hemodynamics after suprarenal ligation of the inferior vena cava and the resection of the right kidney or injection of ligustrazine in rats. Ai Zheng 2004;23:481-486.
8. Ma M, Zhang GJ, Ma Y, Li DH, Zhai HN. Effect of salviae miltiorrhizae and ligustrazine hydrochloride injection on axonal regeneration and nerve growth factor expression in a rat model of sciatic nerve injury. Neural Regen Res 2009;4:1002-1006.
9. Mu YM, Dai Y, Zhang B. Protective effect of tetramethylpyrazine on acute lung injury induced by LPS in mice (in Chinese). China Med 2004;2:43-45.
10. Cai YL, Ren MS, Yang RM, Wang GQ. Observation on Curative Effect of Acute Ischemic Cerebrovascular Disease Treated with Different Dosage of Ligustrazine (in Chinese). Chin J Integr Med 2000;10:747-749.
11. Yu SZ, Li CY. The effects of different doses of tetramethylpyrazine on platelet aggregation of cerebral thrombosis patients (in Chinese). J Apoplexy Nerv Dis 1986;3:148-149.
12. Tibbits J, Cavagnaro JA, Haller CA, Marafno B, Andrews PA, Sullivan JT. Practical approaches to dose selection for first-in-human clinical trials with novel biopharmaceuticals. Regul Toxicol Pharmacol 2010;58:243-251.
13. Sargent EV, Faria E, Pfster T, Sussman RG. Guidance on the establishment of acceptable daily exposure limits (ADE) to support risk-based manufacture of pharmaceutical products. Regul Toxicol Pharmacol 2013;65:242-250.
14. Zhang DH, Tian ZF, Zhao SZ, Jin XS, Cheng SJ. Clinical observation of prophylaxis of venous thrombosis after the great saphenous vein operation with low molecular heparin and ligustrazine injection. Med Res Educ 2011;2:43-45.
15. Chen Z, Li XP. Impaction on blood rheology of chronic pulmonary heart disease in acute phase after treated by tetramethylpyrazine and heparin (in Chinese). China J Chin Med 2010;2:276-278.
16. Kou J, Tian Y, Tang Y, Yan J, Yu B. Antithrombotic activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents. Biol Pharm Bull 2006;29:1267-1270.
17. Yang H, Wang Y, Xiao Y, Wang Y, Wu J, Liu C, et al. A bi-functional anti-thrombosis protein containing both direct-acting fbrin(ogen)olytic and plasminogen-activating activities. PLoS One 2011;6:e17519.
18. Pletcher CH, Cunningham M, Nelsestuen GL. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction. Biochim Biophys Acta 1985;838:106-113.